NEOGENOMICS INC - NOTE 0.250% 1/1

CUSIP: 64049MAB6

Q4 2021 13F Holders as of 31 Dec 2021

SEC-reported market price (% of par)
85.41%
Principal change
-$19,764,594
Number of holders
31
Value change
-$23,948,051
Number of buys
14
Number of sells
19

Security key

64049MAB6

Report period

Q4 2021

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of 64049MAB6 - NEOGENOMICS INC - NOTE 0.250% 1/1 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Principal
$293,181,906
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price (% of par) Principal Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
33
Q4 2021 holders
31
Holder diff
-2
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .